Mirviss Jeffrey B. has filed 55 insider transactions across 1 company since January 2024.
Most recent transaction: a sale of 4675 shares of BOSTON SCIENTIFIC CORP ($BSX) on February 24, 2025.
Activity breakdown: 0 open-market purchases and 11 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 24, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | S | Common Stock | 4675 | $104.25 | 28,454.0000 | 1,485,900,000 | 14.11% | 0.00% |
| Feb. 25, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | S | Common Stock | 2688 | $104.00 | 25,766.0000 | 1,485,900,000 | 9.45% | 0.00% |
| Feb. 19, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | S | Common Stock | 1510 | $105.35 | 33,129.0000 | 1,485,900,000 | 4.36% | 0.00% |
| Feb. 14, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Common Stock | 2776 | $0.00 | 32,477.0000 | 1,485,900,000 | 9.35% | 0.00% |
| Feb. 14, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | F | Common Stock | 1266 | $106.11 | 31,211.0000 | 1,485,900,000 | 3.90% | 0.00% |
| Feb. 16, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Common Stock | 2970 | $0.00 | 34,181.0000 | 1,485,900,000 | 9.52% | 0.00% |
| Feb. 16, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | F | Common Stock | 1355 | $106.11 | 32,826.0000 | 1,485,900,000 | 3.96% | 0.00% |
| Feb. 17, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Common Stock | 3334 | $0.00 | 36,160.0000 | 1,485,900,000 | 10.16% | 0.00% |
| Feb. 17, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | F | Common Stock | 1521 | $106.11 | 34,639.0000 | 1,485,900,000 | 4.21% | 0.00% |
| Feb. 13, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | A | Restricted Stock Units | 5181 | $0.00 | 5,181.0000 | 1,485,900,000 | 9999.99% | 0.00% |
| Feb. 13, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | A | Stock Option (Right to Buy) | 13334 | $0.00 | 13,334.0000 | 1,485,900,000 | 9999.99% | 0.00% |
| Feb. 14, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Restricted Stock Units | 2776 | $0.00 | 5,552.0000 | 1,485,900,000 | 33.33% | 0.00% |
| Feb. 16, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Restricted Stock Units | 2970 | $0.00 | 2,970.0000 | 1,485,900,000 | 50.00% | 0.00% |
| Feb. 17, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Restricted Stock Units | 3334 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| Feb. 12, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Common Stock | 2115 | $0.00 | 30,569.0000 | 1,485,900,000 | 7.43% | 0.00% |
| Feb. 12, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | F | Common Stock | 868 | $105.77 | 29,701.0000 | 1,485,900,000 | 2.84% | 0.00% |
| Feb. 12, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Restricted Stock Units | 2115 | $0.00 | 6,347.0000 | 1,485,900,000 | 24.99% | 0.00% |
| Feb. 11, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | A | Common Stock | 23760 | $0.00 | 52,214.0000 | 1,485,900,000 | 83.50% | 0.00% |
| Feb. 11, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | F | Common Stock | 10738 | $105.98 | 41,476.0000 | 1,485,900,000 | 20.57% | 0.00% |
| Feb. 12, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | S | Common Stock | 13022 | $105.06 | 28,454.0000 | 1,485,900,000 | 31.40% | 0.00% |
| Jan. 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Common Stock | 10430 | $0.00 | 38,884.0000 | 1,485,900,000 | 36.66% | 0.00% |
| Jan. 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | F | Common Stock | 3278 | $89.32 | 35,606.0000 | 1,485,900,000 | 8.43% | 0.00% |
| Jan. 3, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | S | Common Stock | 7152 | $89.86 | 28,454.0000 | 1,485,900,000 | 20.09% | 0.00% |
| Jan. 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Performance Share Units | 10430 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| May 29, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Common Stock | 33726 | $17.26 | 91,824.0000 | 1,463,500,000 | 58.05% | 0.00% |
| May 29, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | S | Common Stock | 63802 | $75.10 | 28,022.0000 | 1,463,500,000 | 69.48% | 0.00% |
| May 29, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Stock Option (Right to Buy) | 33726 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| March 18, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | S | Common Stock | 14506 | $66.45 | 58,098.0000 | 1,463,500,000 | 19.98% | 0.00% |
| Feb. 21, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | S | Common Stock | 4960 | $66.35 | 72,604.0000 | 1,463,500,000 | 6.39% | 0.00% |
| Feb. 16, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Common Stock | 2970 | $0.00 | 75,574.0000 | 1,463,500,000 | 4.09% | 0.00% |
| Feb. 16, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | F | Common Stock | 1355 | $65.82 | 74,219.0000 | 1,463,500,000 | 1.79% | 0.00% |
| Feb. 17, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Common Stock | 3333 | $0.00 | 77,552.0000 | 1,463,500,000 | 4.49% | 0.00% |
| Feb. 17, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | F | Common Stock | 1520 | $65.82 | 76,032.0000 | 1,463,500,000 | 1.96% | 0.00% |
| Feb. 18, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Common Stock | 2817 | $0.00 | 78,849.0000 | 1,463,500,000 | 3.71% | 0.00% |
| Feb. 18, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | F | Common Stock | 1285 | $65.82 | 77,564.0000 | 1,463,500,000 | 1.63% | 0.00% |
| Feb. 16, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Restricted Stock Units | 2970 | $0.00 | 5,940.0000 | 1,463,500,000 | 33.33% | 0.00% |
| Feb. 17, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Restricted Stock Units | 3333 | $0.00 | 3,334.0000 | 1,463,500,000 | 49.99% | 0.00% |
| Feb. 18, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Deferred Stock Units | 2817 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| Feb. 14, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Common Stock | 2776 | $0.00 | 73,870.0000 | 1,463,500,000 | 3.90% | 0.00% |
| Feb. 14, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | F | Common Stock | 1266 | $65.95 | 72,604.0000 | 1,463,500,000 | 1.71% | 0.00% |
| Feb. 14, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Restricted Stock Units | 2776 | $0.00 | 8,328.0000 | 1,463,500,000 | 25.00% | 0.00% |
| Feb. 12, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | A | Restricted Stock Units | 8462 | $0.00 | 8,462.0000 | 1,463,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | A | Stock Option (Right to Buy) | 22311 | $0.00 | 22,311.0000 | 1,463,500,000 | 9999.99% | 0.00% |
| Feb. 6, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | A | Common Stock | 26666 | $0.00 | 83,254.0000 | 1,463,500,000 | 47.12% | 0.00% |
| Feb. 6, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | F | Common Stock | 12160 | $0.00 | 71,094.0000 | 1,463,500,000 | 14.61% | 0.00% |
| Jan. 9, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Common Stock | 15172 | $16.31 | 71,760.0000 | 1,463,500,000 | 26.81% | 0.00% |
| Jan. 9, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | S | Common Stock | 15172 | $59.25 | 56,588.0000 | 1,463,500,000 | 21.14% | 0.00% |
| Jan. 9, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Stock Option (Right to Buy) | 15172 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| Jan. 4, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Common Stock | 15000 | $16.31 | 71,588.0000 | 1,463,500,000 | 26.51% | 0.00% |
| Jan. 4, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | S | Common Stock | 15000 | $58.40 | 56,588.0000 | 1,463,500,000 | 20.95% | 0.00% |
| Jan. 4, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Stock Option (Right to Buy) | 15000 | $0.00 | 15,172.0000 | 1,463,500,000 | 49.71% | 0.00% |
| Jan. 3, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | S | Common Stock | 11931 | $57.82 | 56,588.0000 | 1,463,500,000 | 17.41% | 0.00% |
| Jan. 1, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Common Stock | 17439 | $0.00 | 74,027.0000 | 1,463,500,000 | 30.82% | 0.00% |
| Jan. 1, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | F | Common Stock | 5508 | $57.81 | 68,519.0000 | 1,463,500,000 | 7.44% | 0.00% |
| Jan. 1, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Performance Share Units | 17439 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |